Walleye Capital’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.7M | Buy |
196,361
+124,230
| +172% | +$9.27M | 0.06% | 184 |
|
2025
Q1 | $4.58M | Buy |
+72,131
| New | +$4.58M | 0.02% | 379 |
|
2024
Q4 | – | Sell |
-2,565
| Closed | -$206K | – | 2316 |
|
2024
Q3 | $206K | Sell |
2,565
-2,467
| -49% | -$198K | ﹤0.01% | 1688 |
|
2024
Q2 | $416K | Buy |
+5,032
| New | +$416K | ﹤0.01% | 1526 |
|
2023
Q4 | – | Sell |
-2,257
| Closed | -$202K | – | 2508 |
|
2023
Q3 | $202K | Buy |
+2,257
| New | +$202K | ﹤0.01% | 1491 |
|
2022
Q2 | – | Sell |
-4,111
| Closed | -$260K | – | 2451 |
|
2022
Q1 | $260K | Sell |
4,111
-3,273
| -44% | -$207K | 0.01% | 1346 |
|
2021
Q4 | $392K | Sell |
7,384
-3,037
| -29% | -$161K | 0.01% | 1083 |
|
2021
Q3 | $736 | Buy |
+10,421
| New | +$736 | 0.02% | 578 |
|
2020
Q4 | – | Sell |
-4,349
| Closed | -$379K | – | 990 |
|
2020
Q3 | $379K | Buy |
+4,349
| New | +$379K | 0.04% | 436 |
|
2019
Q2 | – | Sell |
-690
| Closed | -$60K | – | 664 |
|
2019
Q1 | $60K | Buy |
+690
| New | +$60K | 0.01% | 218 |
|